The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon
- PMID: 3322358
- DOI: 10.1111/j.1365-2133.1987.tb07356.x
The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon
Abstract
Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double-blind cross-over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
